Cardiac ischaemia/reperfusion in pigs and mice increases cardiomyocyte Krüppel-like factor 5 that aggravates tissue injury and remodelling
- PMID: 40079359
- PMCID: PMC12160836
- DOI: 10.1093/cvr/cvaf040
Cardiac ischaemia/reperfusion in pigs and mice increases cardiomyocyte Krüppel-like factor 5 that aggravates tissue injury and remodelling
Abstract
Aims: Activation of the transcriptional factor Krüppel-like factor 5 (KLF5) is detrimental to chronic heart failure. We explored the involvement of KLF5 in myocardial ischaemia/reperfusion injury.
Methods and results: Yorkshire pigs underwent 75' of ischaemia, followed by 3 or 24 h of reperfusion. C57BL/6J mice underwent 30' of ischaemia, followed by 10', 2, 12, 24 h, or 4 weeks of reperfusion. Hearts and isolated cardiomyocytes (CMs) were analysed for gene expression. We assessed cardiac function, infarct size (IS), oxidative stress, and fibrosis in mice subjected to pharmacologic or genetic KLF5 inhibition, as well as pharmacologic inhibition of NADPH oxidases or glucose transporter (GLUT)1 and GLUT4. Bulk RNA sequencing, untargeted 1H-NMR metabolomics, and LC-MS lipidomics were performed. Isolated primary murine CMs were infected with recombinant adenovirus expressing KLF5. During reperfusion, CM KLF5 expression was increased in porcine and murine hearts. Pharmacologic or CM-specific genetic inhibition of KLF5 reduced IS and improved cardiac function in mice. Importantly, acute KLF5 inhibition during early reperfusion suppressed fibrosis and preserved systolic cardiac function 4 weeks post-ischaemia/reperfusion. This improvement was associated with lower NADPH-oxidase 4 (NOX4) expression, less oxidative stress, and suppressed inflammation and cell apoptosis. Pharmacologic inhibition of NOX4 conferred the same benefit. Metabolomic analysis indicated that KLF5 inhibition lowered glucose-derived metabolites (UDP-glucose and lactate) at early reperfusion. Accordingly, cardiac GLUT1 and GLUT4 levels were increased with ischaemia/reperfusion, which was reverted by KLF5 inhibition. Pharmacologic inhibition of both GLUT1 and GLUT4 reduced IS. Finally, myocardial KLF5 overexpression increased GLUT1 mRNA levels and mouse mortality.
Conclusion: Ischaemia/reperfusion increases CM KLF5 expression in pigs and mice. This constitutes a central element of myocardial injury pathophysiology and is associated with stimulation of GLUT1 and GLUT4 expression, activation of NOX4, oxidative stress, inflammation, and apoptosis. Acute KLF5 inhibition during reperfusion constitutes a novel therapeutic approach against myocardial ischaemia/reperfusion injury.
Keywords: Cardioprotection; Glucose; Ischaemia/reperfusion; Krüppel-like factor 5 (KLF5); Oxidative stress.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: none declared.
Comment in
-
It takes more than omics to identify a cardioprotective mechanism.Cardiovasc Res. 2025 Jun 12;121(6):839-840. doi: 10.1093/cvr/cvaf052. Cardiovasc Res. 2025. PMID: 40127136 No abstract available.
References
-
- Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–1222. - PMC - PubMed
-
- Heusch G. Myocardial ischemia/reperfusion: translational pathophysiology of ischemic heart disease. Med 2024;5:10–31. - PubMed
-
- Heusch G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 2020;17:773–789. - PubMed
-
- Heusch G. Cardioprotection and its translation: a need for new paradigms? Or for new pragmatism? An opinionated retro-and perspective. J Cardiovasc Pharmacol Ther 2023;28:10742484231179613. - PubMed
-
- Kyriazis ID, Hoffman M, Gaignebet L, Lucchese AM, Markopoulou E, Palioura D, Wang C, Bannister TD, Christofidou-Solomidou M, Oka SI, Sadoshima J, Koch WJ, Goldberg IJ, Yang VW, Bialkowska AB, Kararigas G, Drosatos K. KLF5 is induced by FOXO1 and causes oxidative stress and diabetic cardiomyopathy. Circ Res 2021;128:335–357. - PMC - PubMed
MeSH terms
Substances
Grants and funding
- R01 NS121379/NS/NINDS NIH HHS/United States
- HL45095/HL/NHLBI NIH HHS/United States
- S10 OD032249/OD/NIH HHS/United States
- R01 GM135399/GM/NIGMS NIH HHS/United States
- R37 HL045095/HL/NHLBI NIH HHS/United States
- 1-S10-OD032249-01/National Institute for General Medical Sciences
- R01 HL151924/HL/NHLBI NIH HHS/United States
- GM135399/National Institute for General Medical Sciences
- R01 HL045095/HL/NHLBI NIH HHS/United States
- RF1 NS121379/NS/NINDS NIH HHS/United States
- HL151924/HL/NHLBI NIH HHS/United States
- I01 BX002659/BX/BLRD VA/United States
- R01 HL172926/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
